Zobrazeno 1 - 7
of 7
pro vyhledávání: '"David P. Michelin"'
Autor:
Joyce F. Liu, Mark F. Brady, Ursula A. Matulonis, Austin Miller, Elise C. Kohn, Elizabeth M. Swisher, David Cella, William P. Tew, Noelle G. Cloven, Carolyn Y. Muller, David P. Bender, Richard G. Moore, David P. Michelin, Steven E. Waggoner, Melissa A. Geller, Keiichi Fujiwara, Stacy D. D'Andre, Michael Carney, Angeles Alvarez Secord, Katherine M. Moxley, Michael A. Bookman
Publikováno v:
J Clin Oncol
PURPOSE Platinum-based chemotherapy is the standard of care for platinum-sensitive ovarian cancer, but complications from repeated platinum therapy occur. We assessed the activity of two all-oral nonplatinum alternatives, olaparib or olaparib/cediran
Autor:
David P, Michelin
Publikováno v:
Michigan medicine. 115(1)
Autor:
Michael W. Sill, Parviz Hanjani, Andrew K. Godwin, Robert S. Mannel, Koen De Geest, Jean A. Hurteau, Lydia Usha, Doris M. Benbrook, Kathleen M. Darcy, David P. Michelin
Publikováno v:
Gynecologic Oncology. 121:455-461
Objectives Protein kinase C (PKC) activation contributes to proliferation and angiogenesis in epithelial ovarian or primary peritoneal carcinoma (EOC/PPC). A multi-institutional phase II trial was conducted to evaluate the efficacy and safety of PKC
Autor:
Ana Maria Lopez, David P. Michelin, Mary C Clouser, Maurie Markman, Sharon P. Wilczynski, David S. Alberts, Poching Liu, Victor J. Lanzotti
Publikováno v:
Gynecologic Oncology. 108:90-94
Objective. Because debate continues over the role of combination, platinum-based chemotherapy for platinum-sensitive (PS), recurrent ovarian cancer (OC), we compared overall survival (OS), progression-free survival (PFS), confirmed complete response
Autor:
Kendrith M. Rowland, Maurie Markman, David P. Michelin, David S. Alberts, Garnet L. Anderson, Ana Maria Lopez, Victor J. Lanzotti, Sharon P. Wilczynski, James Moon
Publikováno v:
Gynecologic Oncology. 116:323-325
Randomized phase 3 trials have demonstrated the utility of a regimen of carboplatin plus pegylated liposomal doxorubicin (PLD) in recurrent ovarian cancer, and have provided provocative data suggesting a substantially lower risk of carboplatin-associ
Autor:
Carola Schreckenberger, Andreas M. Kaufmann, Liang Qiao, Susan G. Fisher, Lutz Gissmann, David P. Michelin, Daron Street, Ronald K. Potkul
Publikováno v:
Gynecologic oncology. 66(2)
We examined the in vivo effect of estrogen, progesterone, RU 486, and pregnancy on the upstream regulatory region (URR) of human papillomavirus (HPV) 18 transgenic mice. The mice contain the bacterial reporter beta-galactosidase gene under control of
Publikováno v:
American journal of obstetrics and gynecology. 173(6)
OBJECTIVE: Our purpose was to determine whether a different in clinical outcome could be demonstrated with the choice of Cherney versus vertical incision in patients undergoing surgical treatment of large benign uterine myomas. STUDY DESIGN: Twenty c